# Evaluating Silymarin for Chronic Hepatitis C

> **NCT00030030** · PHASE2 · COMPLETED · sponsor: **National Center for Complementary and Integrative Health (NCCIH)**

## Conditions studied

- Hepatitis C, Chronic

## Interventions

- **DRUG:** Silymarin (milk thistle)

## Key facts

- **NCT ID:** NCT00030030
- **Lead sponsor:** National Center for Complementary and Integrative Health (NCCIH)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-07
- **Primary completion:** —
- **Final completion:** 2002-06
- **Target enrollment:** — (—)
- **Last updated:** 2006-08-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00030030

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00030030, "Evaluating Silymarin for Chronic Hepatitis C". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00030030. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*